Latigo Biotherapeutics (Series B)

Funding Details
Awarder
Inbox
Date Award
May 18, 2025
Vertical
Biotechnology
Funding URL
View Funding Page

Company Info
Company Description
Latigo Biotherapeutics is a clinical-stage biotechnology company developing best-in-class non-opioid pain treatments that target pain at its source.
Market
Pain Treatment
Location
Thousand Oaks, California, USA
Coinvestors
Blue Owl Capital, Deep Track Capital, Access Biotechnology, Qatar Investment Authority, Cormorant Asset Management, Sanofi Ventures, Rock Springs Capital, UPMC Enterprises, Kern Capital, Westlake Village BioPartners, Foresite Capital, 5AM Ventures, Alexandria Venture Investments

Links
Back to Home Back to Biotechnology Deals View Funding Announcement